Last synced on 17 January 2025 at 11:05 pm

Subcutaneous Implanted Apheresis Port

Page Type
Product Code
Definition
A subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis
Physical State
A subcutaneous implanted apheresis port includes the port body, intravascular catheter, and over-the-needle I.V. catheter for port access.
Technical Method
An apheresis port is for patient therapies requiring repeated access to the vascular system. The port system can be used for the infusion of medications, I.V. fluids, parenteral nutrition solutions, blood and blood products, withdrawal of blood and long-term therapeutic apheresis.
Target Area
In accordance with FDA approved labeling, a subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis.
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5965
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter

§ 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter.

(a) Identification. A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.

(b) Classification. Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.

[65 FR 37043, June 13, 2000]

Subcutaneous Implanted Apheresis Port

Page Type
Product Code
Definition
A subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis
Physical State
A subcutaneous implanted apheresis port includes the port body, intravascular catheter, and over-the-needle I.V. catheter for port access.
Technical Method
An apheresis port is for patient therapies requiring repeated access to the vascular system. The port system can be used for the infusion of medications, I.V. fluids, parenteral nutrition solutions, blood and blood products, withdrawal of blood and long-term therapeutic apheresis.
Target Area
In accordance with FDA approved labeling, a subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis.
Regulation Medical Specialty
General Hospital
Review Panel
General Hospital
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
880.5965
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter

§ 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter.

(a) Identification. A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.

(b) Classification. Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.

[65 FR 37043, June 13, 2000]